文献速递神经肿瘤

复发性胶质瘤的进展与展望:基于2019年Web of Science数据库的近期科学计量学分析

Progress and Prospects of Recurrent Glioma: A Recent Scientometric Analysis of the Web of Science in 2019.
PubMed 文献 · World Neurosurg · 2019-10-19

该科学计量学分析在Web of Science数据库中检索复发性胶质瘤相关文章,从4651篇中筛选出被引次数最高的100篇进行评价。结果显示被引次数149至1471次,多数发表于肿瘤学专科期刊(66篇)并由美国机构提交(67篇),其中82篇涉及治疗;作者指出随机对照试验、基础医学研究、文献综述和Meta分析占比较低,亟需开展此类研究。

要点

  • 被引次数最高的100篇复发性胶质瘤文章中,82篇涉及治疗,6篇涉及遗传机制,7篇涉及诊断,5篇涉及预后。
  • 治疗相关文章细分为靶向治疗21篇、化疗20篇、免疫治疗12篇、联合治疗12篇、放疗9篇、手术切除6篇、新疗法(物理治疗)1篇及治疗总结1篇。
  • 作者指出尽管靶向治疗和联合治疗的引用数近年增加,但随机对照试验、基础医学研究、文献综述和Meta分析占比较低,亟需开展此类研究。

核心结论

  • 分析结果表明复发性胶质瘤的核心问题是治疗,且亟需开展随机对照试验、基础医学研究、文献综述和Meta分析。

研究设计与样本

  • 在Web of Science数据库中对复发性胶质瘤文章进行广义检索,从4651篇文章中评价被引次数最高的100篇。

主要发现

  • 被引次数最高的100篇文章引用次数范围为149至1471次,其中66篇发表于肿瘤学专科期刊,67篇由美国机构提交。
  • 被引次数最高的100篇文章包括98篇研究文章和2篇文献综述。
  • 按主题分类:82篇涉及治疗,6篇涉及遗传机制,7篇涉及诊断,5篇涉及预后。
  • 治疗相关文章细分为靶向治疗21篇、化疗20篇、免疫治疗12篇、联合治疗12篇、放疗9篇、手术切除6篇、新疗法(物理治疗)1篇及治疗总结1篇。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most patients with glioma experience recurrence and have a poor prognosis. Scientometric analysis is effective and widely used to summarize the most influential studies within a certain field. We present the first scientometric analysis of recurrent glioma. METHODS: We conducted a generalized search for articles on recurrent glioma in the Web of Science database and evaluated the top 100 most cited articles among 4651 articles. RESULTS: The number of citations from the top 100 cited articles on recurrent glioma ranged from 149 to 1471; most of these articles were published in oncology-specific journals (66) and were submitted by institutions in the United States (n = 67). The top-cited articles consisted of 98 articles and 2 literature reviews. Articles were classified into 4 major categories based on subject matter: 82 pertained to treatment, 6 pertained to genetic mechanisms, 7 pertained to diagnosis, and 5 pertained to prognosis. Treatment-related articles were subdivided into the following 7 categories: targeted therapy (n = 21), chemotherapy (n = 20), immunotherapy (n = 12), combination therapy (n = 12), radiotherapy (n = 9), surgical resection (n = 6), a new therapy (physiotherapy) (n = 1), and treatment summary (n = 1). CONCLUSIONS: The results of the analysis indicated that the core problem is the treatment of recurrent glioma. Although the number of citations on targeted therapy and combination therapy has increased in recent years, the proportion of randomized controlled trials, basic medical research, literature reviews, and meta-analyses is relatively low; thus, there is an urgent need to conduct these types of studies on recurrent glioma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chen W, Lei C, Liu P, et al. Progress and Prospects of Recurrent Glioma: A Recent Scientometric Analysis of the Web of Science in 2019. World Neurosurg. 2019. PMID: 31639500. doi:10.1016/j.wneu.2019.10.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。